港股异动|中国东方集团跌逾3%料中期净利润同比减少约35%-55%
格隆汇8月7日丨中国东方集团(0581.HK)现报3.21港元,跌3.89%,暂成交482万港元,最新总市值119.49亿港元。中国东方集团昨晚发布公告称,预期今年上半年的净利润对比2018年同期将取得约35%-55%的减少。减少主要由于原材料价格上升(特别是铁矿石)导致生产成本增加;及期内因多项生产限制政策的实行而导致产品销量下跌等。公告称,尽管相关期间的净利润预期下降,公司董事局认为集团的整体营运及财务状况仍然健康及稳健。据悉,中国东方集团去年同期公布中期业绩指,期内收入同比增长6.1%至214.7亿元(人民币,下同),净利润同比增长58%至29.59亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.